Coherus biosciences, inc. (CHRS)
Income statement / Yearly
Dec'19Dec'18Dec'17Dec'16Dec'15Dec'14Dec'13Dec'12
Revenue:
Total revenue

356,071

0

1,556

189,476

-

-

-

-

Collaboration and license revenue

-

-

-

-

30,041

30,374

2,751

1,899

Other revenue

-

-

-

630

-

732

-

-

Total revenue

-

-

-

190,106

30,041

31,106

2,751

1,899

Operating expenses:
Cost of goods sold

17,078

0

0

-

-

-

-

-

Research and development

94,188

110,239

162,389

254,440

213,062

78,224

31,279

34,886

Selling, general and administrative

137,037

94,177

71,303

51,597

36,046

17,564

7,465

5,531

Total operating expenses

248,303

204,416

233,692

306,037

249,108

95,788

38,744

40,417

Income (loss) from operations

107,768

-204,416

-232,136

-115,931

-219,067

-64,682

-35,993

-38,518

Interest expense (includes related party of $620 and $610 for the three months ended March 31, 2020 and 2019, respectively)

17,601

9,684

9,552

7,980

33

3,900

5,293

1,514

Other income, net

2,608

4,691

3,402

-3,877

-4,838

-18,595

-12,349

7,014

Net income (loss) before income taxes

92,775

-209,409

-238,286

-

-

-

-

-

Income tax provision

2,900

0

0

-

-

-

-

-

Net income (loss)

89,833

-209,409

-238,286

-127,788

-223,938

-87,177

-53,635

-33,018

Net loss attributable to non-controlling interest

0

-70

-116

-451

-678

-44

-

-

Net income (loss)

89,833

-209,339

-238,170

-127,337

-223,260

-87,133

-53,635

-33,018

Net loss per share attributable to Coherus, basic and diluted

-

-

-

-3.04

-6.01

-10.64

-16.10

-15.85

Weighted-average number of shares used in computing net loss per share attributable to Coherus, basic and diluted

-

-

-

41,912

37,122

8,186

3,332

2,082

Net income (loss) per share:
Basic

1.29

-3.22

-4.48

-

-

-

-

-

Diluted

1.23

-3.22

-4.48

-

-

-

-

-

Weighted-average number of shares used in computing net income (loss) per share:
Basic

69,679

65,034

53,133

-

-

-

-

-

Diluted

73,185

65,034

53,133

-

-

-

-

-

Net Product Revenue
Total revenue

356,100

0

0

-

-

-

-

-

Collaboration and License Revenue
Total revenue

0

0

1,556

-

-

-

-

-